Literature DB >> 10880962

Expression patterns of the regulatory proteins G protein-coupled receptor kinase 2 and beta-arrestin 1 during rat postnatal brain development: effect of hypothyroidism.

P Penela1, M Alvarez-Dolado, A Muñoz, F Mayor.   

Abstract

G protein-coupled receptor kinase 2 (GRK2) and beta-arrestin 1 are key regulatory proteins that modulate the desensitization and resensitization of a wide variety of G protein-coupled receptors (GPCRs) involved in brain functions. In this report, we describe the postnatal developmental profile of the mRNA and protein levels of GRK2 and beta-arrestin 1 in rat brain. The expression levels of GRK2 and beta-arrestin 1 display a marked increase at the second and third week after birth, respectively, consistent with an involvement of these proteins in brain maturation processes. However, the expression attained at birth and during the first postnatal week with respect to adult values (45-70% for GRK2, approximately 30% for beta-arrestin 1) is relatively high compared to that reported for several GPCRs, indicating the existence of changes in the ratio of receptors to their regulatory proteins during brain development. On the other hand, we report that experimental hypothyroidism results in changes in the patterns of expression of GRK2 and beta-arrestin 1 in cerebral cortex, leading to a 25-30% reduction in GRK2 levels at several stages of development. Such changes could help to explain the alterations in GPCR signaling that occur during this pathophysiological condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880962     DOI: 10.1046/j.1432-1327.2000.01484.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

Review 2.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 3.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

4.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

5.  Thyroid Hormone-Induced Differentiation of Astrocytes is Associated with Transcriptional Upregulation of β-arrestin-1 and β-adrenergic Receptor-Mediated Endosomal Signaling.

Authors:  Moitreyi Das; Mausam Ghosh; Sumantra Das
Journal:  Mol Neurobiol       Date:  2015-09-23       Impact factor: 5.590

6.  Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.

Authors:  Mark E Obrenovich; Mark A Smith; Sandra L Siedlak; Shu G Chen; Jack C de la Torre; George Perry; Gjumrakch Aliev
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

7.  Hypothyroidism during neonatal and perinatal period induced by thyroidectomy of the mother causes depressive-like behavior in prepubertal rats.

Authors:  Marisol Pineda-Reynoso; Edgar Cano-Europa; Vanessa Blas-Valdivia; Adelaida Hernandez-Garcia; Margarita Franco-Colin; Rocio Ortiz-Butron
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 8.  Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.

Authors:  Mark E Obrenovich; Ludis A Morales; Celia J Cobb; Justin C Shenk; Gina M Méndez; Kathryn Fischbach; Mark A Smith; Eldar K Qasimov; George Perry; Gjumrakch Aliev
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

9.  μ-Opioid receptor desensitization: homologous or heterologous?

Authors:  Javier Llorente; Janet D Lowe; Helen S Sanderson; Elena Tsisanova; Eamonn Kelly; Graeme Henderson; Chris P Bailey
Journal:  Eur J Neurosci       Date:  2012-09-24       Impact factor: 3.386

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.